Active Ingredient(s): Fospropofol Disodium
FDA Approved: * December 12, 2008
Pharm Company: * EISAI MEDCL RES
Category: Intravenous (IV) Therapy

Fospropofol (INN[3]), often used as the disodium salt (trade name Lusedra[4]) is an intravenous sedative-hypnotic agent. It is currently approved for use in sedation of adult patients undergoing diagnostic or therapeutic procedures such as endoscopy. Contents 1 Clinical applications 2 Clinical pharmacology 2.1 Mechanism of action 2.2 Pharmacodynamics 2.3 Pharmacokinetics 3 Controlled substance 4 References Clinical applications Several water-soluble ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Lusedra 35 mg/ml Intravenous Injection
NDC: 62856-350
Eisai, Inc